Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
•
Primary Care
How do you manage a patient who is reliant on NSAIDs for arthritis but has developed PUD?
Would you consider COX-2 selective inhibition, PPI, PCAB, or some combination thereof?
Related Questions
Are there data to support the use of herbal supplements, prebiotics, or probiotics in the management of SIBO?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
How do you approach surveillance of gastric hyperplastic polyps of various sizes?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
Can patients "age out" of screening colonoscopies if, on their last colonoscopy prior to turning 76, they had tubular adenomas?
How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?
In patients with longstanding UC or Crohn's colitis, would you extend the interval of surveillance colonoscopy to longer than 3 years if they have had little inflammatory disease over the years and no other factors to increase their risk (ie, history of polyps, history of dysplasia, or family history)?
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
Is there evidence that certain PPIs provide superior clinical efficacy compared to others in real-world practice?
How do you approach a referral for findings of intestinal metaplasia on a biopsy of an irregular z-line?